|
SMAP1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.768800E-04 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.984400E-02 |
| Normal-vs-Stage2 |
1.403840E-01 |
| Normal-vs-Stage3 |
1.957510E-03 |
| Normal-vs-Stage4 |
1.696410E-01 |
| Stage1-vs-Stage2 |
9.026800E-01 |
| Stage1-vs-Stage3 |
3.251500E-02 |
| Stage1-vs-Stage4 |
3.915800E-01 |
| Stage2-vs-Stage3 |
1.312830E-01 |
| Stage2-vs-Stage4 |
4.844600E-01 |
| Stage3-vs-Stage4 |
6.568800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.395100E-03 |
| Normal-vs-AfricanAmerican |
1.524000E-03 |
| Normal-vs-Asian |
6.952600E-01 |
| Caucasian-vs-AfricanAmerican |
1.592000E-01 |
| Caucasian-vs-Asian |
7.705600E-01 |
| AfricanAmerican-vs-Asian |
4.893200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.982100E-03 |
| Normal-vs-Female |
1.371700E-04 |
| Male-vs-Female |
4.011900E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.735560E-01 |
| Normal-vs-Extreme_Weight |
3.511200E-01 |
| Normal-vs-Obese |
4.975500E-04 |
| Normal-vs-Extreme_Obese |
5.071400E-01 |
| Normal_Weight-vs-Extreme_Weight |
4.409000E-01 |
| Normal_Weight-vs-Obese |
1.262230E-01 |
| Normal_Weight-vs-Extreme_Obese |
9.825000E-01 |
| Extreme_Weight-vs-Obese |
5.976000E-03 |
| Extreme_Weight-vs-Extreme_Obese |
6.610600E-01 |
| Obese-vs-Extreme_Obese |
3.550200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.942000E-02 |
| Normal-vs-Age(41-60Yrs) |
3.58820000000426E-05 |
| Normal-vs-Age(61-80Yrs) |
3.754200E-02 |
| Normal-vs-Age(81-100Yrs) |
4.603200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.978200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.107800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.060400E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.766100E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.882400E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.875610E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
6.201600E-04 |
| Normal-VS-Type2 PRCC |
5.372000E-02 |
| Normal-VS-KIRP CIMP |
4.008900E-04 |
| Normal-VS-Unclassified PRCC |
6.065600E-02 |
| Type1 PRCC-VS-Type2 PRCC |
6.221000E-01 |
| Type1 PRCC-VS-KIRP CIMP |
2.445000E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
7.906000E-01 |
| Type2 PRCC-VS-KIRP CIMP |
2.619000E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
5.794200E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
5.094400E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.804240E-01 |
| Normal-vs-N1 |
7.047000E-04 |
| Normal-vs-N2 |
9.516400E-01 |
| N0-vs-N1 |
3.588400E-02 |
| N0-vs-N2 |
6.935400E-01 |
| N1-vs-N2 |
1.262970E-01 |
|
|
